Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arterial Vascular Engineering AVEI -- Ignore unavailable to you. Want to Upgrade?

To: Dave Chanoux who wrote (404)	11/25/1998 12:29:00 PM
From: mmeggs	Respond to of 410

I'm not sure. I don't know MDT's product line well enough to say for certain. The headline says it sold off the non-vascular stent business, but also notes that VascuCoil was included in the transaction. Anyone know if MDT has other vascular stents? Agreed the op was a loser, for whatever reason -- nowhere close to the four other major stent players. Probably was a giveaway. Financial terms were not disclosed. Oh well, we'll see it in the next earnings report probably. Happy T-day, mmeggs